The UMMC Office of Clinical Trials works directly the Sponsors/CROs to expedite study activation of clinical trials. We will work closely with you to achieve a shared goal of attaining study activation while maintaining the highest level of accuracy.
At UMMC, we have three phases of activities to prepare a new industry-sponsored study: sponsor document collection; study development; and activation.
Sponsor Document CollectionThe first step in this process is collecting information from you that is vital to UMMC during the study development and activation process. If applicable to your trial, the specific documents that we require are:
The information in these documents is required for study development within UMMC. Our study staff are instructed to wait for the receipt of all applicable documents before moving forward with the initiation of the IRB application, budget, and contract process. Since the study development process will not begin until we have received these documents, your timely attention is appreciated.
Study Development (timeline goal: ~4 weeks)Once all study documents are received, the investigative team will begin the necessary activities to enter the activation process as applicable, including:
Activation Process (timeline goal: ≤65 days, pending project type and your commitment to timelines)Budget creation and negotiation, contract negotiation, and IRB committee reviews are completed in parallel. The Office of Clinical Trials will contact you during the Study Development process once we have developed the activation timeline. We will provide you with the anticipated dates for receipt of budget, contract redlines, and IRB approval from UMMC. In our accelerated process, we aim to complete these three activities in parallel with your commitment to this accelerated review schedule.
If you have any questions regarding the process to develop and activate a study at UMMC, please contact the Office of Clinical Trials at firstname.lastname@example.org or (601) 815-5000. We look forward to working with you.